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Although endocrine abnormalities are recognized in opiate users, very little is known about the range of hormones affected, their pathophysiology and their clinical relevance. Various endocrine abnormalities have been reported in these patients including, increased 
prolactin levels and abnormalities in sexual hormone. Path physiological mechanism postulated 
does explain these findings including direct action of heroin or methadone at the hypothalamic 
pituitary level. The aim of this study was to explore the effects of heroin and methadone mainte-
nance treatment on the plasma prolactin levels and sexual function. Material and methods: We 
evaluated 20 male narcotic addicts maintained of methadone more than 3 years on oral high dose 
methadone 60-120 mgr/day. Patients taking neuroleptic therapy were excluded from the study 
because neuroleptic-included hyperprolactinemia. We also evaluated group of twenty male heroin 
addicts on the street heroin .The prolactin plasma levels were assayed using the chemiluminescent 
immunometric essay (CLIA) - high sensitive methods, The normal range of prolactin levels was 
1,5-17 ng/ml(53-360 nmol/l) for men and 1,90-25,0 ng/ml for women. The sexual function was 
assessed using a Questionnaire: International Index of Erectile Function (IIEF) with 15 items in 
four levels of sexual function. The differences between two examination groups were determined 
by a student’s t test. The results show that street heroin addicts (55% of them have high level of 
prolactin) have significantly higher plasma prolactin levels (p=0,006) then the group of methadone 
maintenance patients (only 15% of them have high prolactin level). In our study, when we compared 
sexual dysfunction in examination groups in some domains, we did not find statistical significant 
results (sexual desire p=0,52 and overall satisfaction p=0,087). But in domains of erectile function 
p=0,011 and orgasm function p=0,033 we got statistical significant results. Key words: heroin 
addiction, methadone maintenance therapy, sexual dysfunction, prolactin plasma levels.
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1. inTroDUCTion
Although endocrine abnormalities are 
recognized in opiate users in literature re-
search very little is known about the range 
of hormones affected, their pathophysi-
ology, and their clinical relevance. Vari-
ous endocrine abnormalities have been 
reported in these patients, which in-
cluded: increased levels of thyroxine (T4), 
Triiodothyronine(T3) and thyroxine bind-
ing globulin (TBG), insulin and glucose 
metabolism abnormalities similar to those 
seen in type 2 diabetes, increased prolactin 
levels, reduction in testosterone levels and 
abnormalities in follicular stimulating hor-
mone levels. Pathophysiological mechanism 
postulated does explain these findings in-
cluding a direct action of heroin or metha-
done at the hypothalamic or pituitary lev-
els. Some literature research conclude that 
many of the hypothalamic and anterior pi-
tuitary hormones are adversely affected in 
heroin misuses and methadone maintained 
patients (1). But, one of the most seriously 
endocrine abnormalities in opiate users and 
methadone maintenance patients is hyper-
prolactinemia and sexual dysfunction as a 
side–effects of opioid induced hyperpro-
lactinemia (2). Prolactin is synthesized and 
secretion by lacto trope cells in adenophy-
pophysis (anterior pituitary gland). Pitu-
itary prolactin secretion is regulated by neu-
roendocrine neurons in the hypothalamus, 
the most important ones being the neuro-
secretory tuberoinfundibulum (TIDA) neu-
rons of the arcuate nucleus with secrete do-
pamine to act on the dopamine -2 receptors 
(D2-R) of lactotrophs causing inhibition of 
prolactin secretion. So, dopamine has an 
inhibitory effect on prolactin excretion (3, 
4). Pathophysiological mechanism postu-
lated does explain these findings included 
a direct action of heroin or methadone at 
the hypothalamic or pituitary level. In all 
parts of the brain, opioids stimulate dopa-
mine production engendering analgesia, eu-
phoria, and other reward effects of opioids. 
Only in the hypothalamus opioids decreas-
ing dopamine secretion, it produces excess 
amounts of prolactin a condition influenc-
ing sexual dysfunction called hyperpro-
lactinemia (5). Hyperprolactinemia acts to 
gonad function included reproductive dys-
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function (an ovulation, fertility. Decreased 
estrogen and testosterone production) and 
sexual dysfunction (sexual impairment, 
erectile dysfunction, retrograde or pain-
ful ejaculation, orgasmic dysfunction) (6, 
7). However some research study reported 
that steady-state pharmacokinetics prop-
erties of methadone allow adaptation and 
normalization of endocrine and neuroen-
docrine function. So optimum methadone 
doses tend to stabilize hormonal balances 
over time (6).
The AIM of this study was to explore 
the effects of heroin and methadone main-
tenance therapy on the plasma prolactin 
levels and sexual function in men.
2. MATeriAl AnD MeTHoDS
The present study included two groups 
of heroin addicts. The first group A in-
cluded 20 male heroin addicts who was on 
the street heroin. The second B group con-
sisted of twenty male heroin addicts who 
were on the methadone maintenance ther-
apy more than 3 years, on oral high dose 
methadone 60-120 mgr/day. After complete 
description on the study, a written informed 
consent was obtained. Confidentially of in-
formation was assured. The study protocol 
was approved by the local ethics commit-
ment and is consistent with the Helsinki 
declaration. All the patients followed crite-
ria for opioid dependence and had no other 
significant psychiatric diagnosis. Especially 
patients with neuroleptic therapy were ex-
cluded from the study because neuroleptic 
therapy induced hyperprolactinemia. Crite-
ria to elimination was: chronic liver or renal 
diseases or other chronic physical disorders, 
HIV diseases or active infection. All the pa-
tients there followed by routine medical ex-
amination, with included blood chemistry, 
urine analysis and serology for hepatitis and 
HIV infection. Hormone assays: blood sam-
ples of all patients and heroin street addicts 
were obtained the morning between 09.00-
11.00 H. The prolactin plasma levels were 
assayed using the chemiluminescent immu-
nometric assay (CLIA)-high sensitive meth-
ods. The normal range of prolactin level was 
1,5-17,0 ng/ml for men and 1,90-25,0 ng/ml 
for women. Sexual function in males was 
assessed by using the Questionnaire (IIEF) 
which contains 15 items. All the items are 
scored in 4 domains (erectile function, or-
gasmic function, sexual desire, overall sat-
isfaction). Final scores can be interpreted 
as following score: severe, moderate, mild 
to moderate, mild, and without dysfunc-
tion. The differences of hormone levels and 
scores of sexual dysfunction among the 
groups were compared by using the t-test 
for independent samples.
3. reSUlTS
Hormone analysis in our study show 
that 55 percent of heroin addicts have high 
plasma prolactin levels and 45% of them 
have normal prolactin levels. Also in the 
group with methadone maintenance pa-
tients we got 85 percent with normal prolac-
tin levels and 15% with high prolactin lev-
els. But no one in both examination groups 
had a low prolactin levels (Table 1). Also the 
results in this study reported that group 
of street heroin addicts had significantly 
higher plasma prolactin levels (p<0, 05) 
then group of patients treated with meth-
adone therapy using t-test for independent 
samples (Table 2).
In the group of patients on methadone 
maintenance therapy 55% of them have 
erectile dysfunction, 45% of them have no 
erectile dysfunction; 65% of them have or-
gasm dysfunction and 35% of them have 
no orgasm dysfunction. With dysfunc-
tion in sexual desire (libido) in this group 
we found that in 55% of causes we got dys-
function in libido, but in 45% of the subjects 
we got results with no dysfunction in sex-
ual desire (libido). In patients treated with 
methadone therapy dysfunction in overall 
satisfaction was noticed in 65% of causes 
and in 35 % of subjects we got no dysfunc-
tion in overall satisfaction (Table 3 ). In the 
group of street heroin addicts 85% of them 
have erectile dysfunction and only 15% of 
them have no erectile dysfunction. In this 
group we got that 85% of them have orgasm 
dysfunction and 15% of them do not have 
orgasm dysfunction. With dysfunction in 
sexual desire (libido) in this group we got 
in 80% of causes, also in 20% of the subjects 
we got results with no dysfunction in sexual 
desire (libido). Dysfunction in overall satis-
faction we got in 85% of causes but in only 
15 % of the subjects we got no dysfunction 
in overall satisfaction (Table 4).
In our study we got the results which 
generally have no statistical significant dif-
ferences between sexual dysfunction in the 
examination groups. Results showed that 
scores of the Questionnaire IIIEF in meth-
adone maintenance patients aren’t decreas-
ing significantly in some domains (sex-
ual desire, overall satisfaction p>0, 05) but 
not in all domains when compare with the 
group of street heroin addicts. So in the do-
mains of erectile function and orgasm func-
tion we got statistical significant results (p< 
0,05) (Table 5).
4. DiSCUSSion
This study demonstrated that serum 
prolactin levels in former heroin addicts 
on stabile-dose of methadone therapy were 
significantly lower than the serum prolac-
tin level observed in groups of street her-
oin addicts. In our study we found that 85 
percent of patients in methadone mainte-
nance treatment have a normal prolactin 
level. This results correlate with another 
prospective studies which show that hor-
monal levels return to normal after three 
or more years of chronic methadone treat-
ment. So, same studies report that stabile 
dose of methadone therapy always normal-
ize in responsively of several psychological 
system hypothalamic-pituitary-adrenal, hy-
pothalamic-pituitary- gonad and immune 
system). Optimum methadone doses tend 
to stabilize hormonal balances over time 
(8, 9). But in our study we got that 15% per-
cent of methadone maintenance patients 
had a high level of serum prolactin, this 
results compare with another studies who 
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in overall satisfaction (Table4 ). 
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In our study we got the results which   generally have no statistical  significant differences between 
sexual dysfunction in the examination groups. Results showed that scores of the Questionnaire 
IIIEF in methadone maintenance patients aren’t decreasing significantly in some domains (sexual 
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Table 5 .Statistical significances between 4 domains of sexual dysfunction in examination groups. 
Table 3. Distribution on sexual dysfunction (percentage and number 
of patients in group of methadone maintenance patients
Table 3. Distribution on sexual dysfunction (percentage and number of patients in group of 
methadone maintenance patients 
Domains of                                                             Scored in domains                              
SD in IIEF                 severe        moderate       mild to moderate         mild     no disfunction 
Erectile fuction               /              6(30%)            2(10%)                      3(15%)       9(45%)                                   
Orgasmic function       3 (15%)     4(20%)             2(10%)                    4(20%)       7(35%)            
 sexual desire                 8(40%)     1(5%)              1(5%)                        1(5%)           9(45%) 
 overall satisfaction        5(25%)     4(20%)           3(15%)                      1(5%)          7(35%) 
 
 
 
 
Table 4.  Distribution on sexual dysfunction (percentage and number of patients  in heroin addicts 
group. 
Scored in domains 
Domains of IIEF       severe        moderate       mild to moderate         mild     no disfunction. 
Erectile fuction               /             12(60%)            3(15%)                      2(10%)       3(15%)                                   
Orgasmic function        7(35%)     3(15%)             5((25%)                     2(10%)      3(15%)            
sexual desire                7(35%0     2(10%)            4(20%)                   3(15%)            4(20%) 
overall satisfaction        7(35%)     6(30%)            2(10%)                   2(10%)          3(15%) 
 
In our study we got the results which   generally have no statistical  significant differences between 
sexual dysfunction in the examination groups. Results showed that scores of the Questionnaire 
IIIEF in methadone maintenance patients aren’t decreasing significantly in some domains (sexual 
desire, overall satisfaction p>0, 05) but not in all domains when compare with the group of street 
heroin addicts. So in the domains of erectile function and orgasm function we got statistical
significant results (p< 0,05) (Table 5). 
Table 5 .Statistical significances between 4 domains of sexual dysfunction in examination groups. 
Table 4.  Distribution on sexual dysfunction (percentage and number 
of patients  in roin addicts group.
 
Group        erectile function,       orgasm function,         sexual desire     overall .satisfaction. 
A group               6,90±1,54                2,84±0,63                 2,96±0,66              4,38±0,97 
B group               8,34±1,86                 3,03±0,68                  3,81±0,85             4,28±0,96 
Student’s  t-test    p=0,011                   p=0,033                         p=0,52                p=0,087 
 
4. DISCUSSION 
This study demonstrated that serum prolactin levels in former heroin addicts on stabile-dose 
of methadone therapy were significantly lower than the serum prolactin level observed in 
groups of street heroin addicts. In our study we found that 85 percent of patients in 
methadone maintenance treatment have a normal prolactin level. This results correlate with 
another prospective studies which show that hormonal levels return to normal after three or 
more years of chronic methadone treatment.  So, same studies report that stabile dose of 
methadone therapy always normalize in responsively of several psychological system 
hypothalamic-pituitary-adrenal, hypothalamic-pituitary- gonad and immune system). 
Optimum methadone doses tend to stabilize hormonal balances over time (8,9). . But   in 
our study we got that 15% percent of methadone maintenance patients had a high level of 
serum prolactinl, this results compare with another studies who reported that after two   or 
more years of chronic high dose of methadone treatment galactorrhoea and another side 
effects of hyperprolactinemia may persist (10).  However some studies reported that in 
ce tral patient in methadone maintenance treatment   increase prolactin levels may persist 
long time. These results may be modulated by   developing the tolerance to dopaminergic 
effects (tonic-inhibitory controls) of chronic stable dose of methadone treatment (8). But in 
our study we got result with significant differences between groups of methadone 
maintenance patients and heroin street addicts (p<0, 05). So we  got higher levels of 
prolactin  in the group of street heroin addicts and these results correlation with another 
studies which reported that consequently, the high plasma prolactin levels and sexual 
dysfunction (SD) as  side effects of hyperprolactinemia were found  among the patients 
who entering into  addiction treatment . Most substances of abuse and dependency 
potentially wreak havoc on sexual performance and reproductive function. Thereafter, 
sexual dysfunction (SD) is apparently common among patents coming into additions 
treatment.  Studies have found that up to 78% of families and 85% of males entering 
methadone maintenance treatment had sexual difficulties while using heroin(11).  Also in 
our study    we found that among group of street heroin addicts 85% of them have erectile 
dysfunction, 85% of them have orgasm dysfunction, 80%   have dysfunction of sexual 
Table 5 .Statistical significances between 4 domains of sexual 
dysfunction in examination groups.
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reported that after two or more years of 
chronic high dose of methadone treatment 
galactorrhoea and another side effects of hy-
perprolactinemia may persist (10). However 
some studies reported that in central pa-
tient in methadone maintenance treatment 
increase prolactin levels may persist long 
time. These results may be modulated by 
developing the tolerance to dopaminergic 
effects (tonic-inhibitory controls) of chronic 
stable dose of methadone treatment (8). But 
in our study we got result with significant 
differences between groups of methadone 
maintenance patients and heroin street ad-
dicts (p<0, 05). So we got higher levels of 
prolactin in the group of street heroin ad-
dicts and these results correlation with an-
other studies which reported that conse-
quently, the high plasma prolactin levels 
and sexual dysfunction (SD) as side effects 
of hyperprolactinemia were found among 
the patients who entering into addiction 
treatment. Most substances of abuse and 
dependency potentially wreak havoc on 
sexual performance and reproductive func-
tion. Thereafter, sexual dysfunction (SD) is 
apparently common among patents com-
ing into additions treatment. Studies have 
found that up to 78% of families and 85% 
of males entering methadone maintenance 
treatment had sexual difficulties while us-
ing heroin (11). Also in our study we found 
that among group of street heroin addicts 
85% of them have erectile dysfunction, 85% 
of them have orgasm dysfunction, 80% have 
dysfunction of sexual desire and in 85% of 
cases we got dysfunction in overall satis-
faction. These results may be modulated by 
develop the tolerance to dopaminergic ef-
fects (tonic-inhibitory controls) of chronic 
stable-dose methadone treatment (6, 7). 
Some studies reported that patients taking 
methadone had a very high frequency of 
sexual dysfunction; libido was reduced in 
83% and potency was reduced in 72 % (12). 
The study of Brown et al also reports that in 
group of methadone maintenance patients 
fourteen percent have some sexual dysfunc-
tion: erectile dysfunction (r=0.24, p=0.20) 
libido dysfunction (r=0.30, p=0.003) and 
global dysfunction(r-0.26, p=0.13) orgasm 
dysfunction (p=0.012) (13). After three 
years or more of chronic high dose metha-
done treatment in 50 % of patients persis-
tent abnormalities in libido and sexual per-
formance. Ricardo and all in our studies re-
port that among 50 MMT patients 53% had 
erectile dysfunction (ED); 26% had moder-
ate to severe erectile dysfunction (14, 15). 
Some studies found that testosterone level 
remain decreased with SD in around 50-
60% of patients after one years of chronic 
treatment. However in central patients in-
crease prolactin levels and SD may persist 
long time (7). Some studies reported very 
provocative finding of elevation levels of 
prolactin and decrease levels of testoster-
one and sexual dysfunction in significant 
percentage of MMT patients. They return 
to the normal pattern during variation fol-
lowing detoxification from methadone (16).
In our study we also got results which 
show that stabile methadone dose return 
sexual hormone in normal level and de-
crease sexual dysfunction as side effects of 
hyperprolactinemia. Among group of pa-
tients on methadone maintenance therapy 
45% of them have no erectile dysfunction, 
35% of them have no orgasm dysfunction. 
Also in 45% of the subjects we got results 
with no dysfunction in sexual desire (libido) 
and in 35 % of subjects we got no dysfunc-
tion in overall satisfaction. These results 
correlation with other prospective studies 
which found that testosterone level return 
to normal range with decrease the sexual 
dysfunction (8, 9). Also some prospective, 
retrospective and special studies reported 
that after 3 years or more of chronic high-
dose methadone treatment full stabiliza-
tion has been achieved (7). So stabile dose 
of methadone therapy always normalize in 
responsively of several physiological system; 
hypothalamic-pituitary-adrenal system. 
Optimum methadone doses tend to stabi-
lize hormonal balances over time (9). But in 
our study we also got the results which gen-
erally have not statistical significant differ-
ences between sexual dysfunction in both 
examination groups. Results showed that 
scores of Questionnaire (IIIEF) in metha-
done maintenance patients decrease sig-
nificant in some domains as erectile func-
tion and orgasm function (p<0, 05) but not 
in all domains then groups of street heroin 
addicts. So in the domains of sexual desire 
and overall satisfaction we got not statisti-
cal significant results (p>0, 05).
5. ConClUSion
In our study we got results with higher 
plasma prolactin level and sexual dysfunc-
tion in a group of methadone maintenance 
patients. So, the patients of methadone 
treatment attempt to solve this problem 
many person believe that stimulants such 
as cocaine or amphetamine enhance sexual 
function, so patients may resort self-med-
ication with such as stimulants, by reduc-
tion doses of prescribed medication, dis-
continuation of MMT or are dropping out 
of the treatment.
So replacement treatment with dopa-
mine agonist bromocriptin, and buprenor-
phine as a opiate antagonist maybe dimin-
ished the effects of hyperprolactinemia 
among the heroin addicts and methadone 
maintenance patients (15, 16). Furthermore 
patients and staff need education regarding 
the psychological and psychological im-
pact of drug. So, the patients which enter 
in methadone maintenance treatment need 
education of hormonal disorders as a side 
effects of opioid addiction and their sexual 
and reproductive health. In this way some 
condition with hormonal disorders in opi-
ate addicts may be rapidly detect and rap-
idly affect with some therapeutic models.
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